Novo Nordisk Stumbles Amidst Eli Lilly’s Triumphant Rise: What’s Next
In the high-stakes world of pharmaceutical giants, fortunes can shift dramatically and with little warning. Just ask Novo Nordisk, which recently faced a significant stumble in its long-standing reign over the diabetes and obesity treatment market. The company is grappling...
